Skip to main content

Supreme Court abortion pill case puts FDA drug review power at risk

By Axios  
   December 14, 2023

The Supreme Court's decision to review the availability of a commonly used abortion pill is a direct challenge to the FDA's power to regulate drugs.

Full story


Get the latest on healthcare leadership in your inbox.